REGISTERED NUMBER: 07482655 (England and Wales)

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 JANUARY 2025

FOR

EPIGENETICS LTD

Page

Company Information

1

Accountants' Report

2

Balance Sheet

3

to

4

Notes to the Financial Statements

5

to

9

DIRECTORS:

Mr C R Astill-Smith

Miss G J Farr

REGISTERED OFFICE:

First Floor North

40 Oxford Road

High Wycombe

Buckinghamshire

HP11 2EE

REGISTERED NUMBER:

07482655 (England and Wales)

ACCOUNTANTS:

Seymour Taylor Limited

First Floor North

40 Oxford Road

High Wycombe

Buckinghamshire

HP11 2EE

The following reproduces the text of the report prepared for the directors in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance Sheet. Readers are cautioned that the Income Statement and certain other primary statements and the Report of the Directors are not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Epigenetics Ltd for the year ended 31 January 2025 which comprise the Income Statement, Balance Sheet, Statement of Changes in Equity and the related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed within the ICAEW's regulations and guidance at http://www.icaew.com/en/membership/regulations-standards-and-guidance.

This report is made solely to the Board of Directors of Epigenetics Ltd, as a body, in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of Epigenetics Ltd and state those matters that we have agreed to state to the Board of Directors of Epigenetics Ltd, as a body, in this report in accordance with ICAEW Technical Release 07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Epigenetics Ltd and its Board of Directors, as a body, for our work or for this report.

It is your duty to ensure that Epigenetics Ltd has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Epigenetics Ltd. You consider that Epigenetics Ltd is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Epigenetics Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

Seymour Taylor Limited

First Floor North

40 Oxford Road

High Wycombe

Buckinghamshire

HP11 2EE

31 October 2025

FIXED ASSETS

Tangible assets

4

327,835

165,590

CURRENT ASSETS

Stocks

433,212

381,796

Debtors

5

19,908

82,982

Cash at bank and in hand

350,957

141,187

804,077

605,965

CREDITORS

Amounts falling due within one year

6

485,146

322,117

NET CURRENT ASSETS

318,931

283,848

TOTAL ASSETS LESS CURRENT LIABILITIES

646,766

449,438

CREDITORS

Amounts falling due after more than one year

7

(3,333

)

(28,009

)

PROVISIONS FOR LIABILITIES

(58,824

)

(41,498

)

NET ASSETS

584,609

379,931

CAPITAL AND RESERVES

Called up share capital

9

100

100

Retained earnings

584,509

379,831

SHAREHOLDERS' FUNDS

584,609

379,931

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 January 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 January 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 31 October 2025 and were signed on its behalf by:

Miss G J Farr - Director

1.	STATUTORY INFORMATION

Epigenetics Ltd is a private company limited by shares and incorporated in England and Wales. The address of the company's registered office is First Floor North, 40 Oxford Road,, High Wycombe, Buckinghamshire, HP11 2EE. The registered number is 07482655.

The presentation currency of these financial statements is Sterling (£), being the currency of the primary economic market in which the entity operates (its functional currency). All amounts in these financial statements have been rounded to the nearest pound unless stated otherwise.

The significant accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all years presented unless otherwise stated.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimate useful life or, if held under a finance lease, over the lease term, whichever is the shorter.

Plant and machinery - reducing balance - 25%

Fixtures and fittings - reducing balance - 15%

Computer equipment - straight line - 33%

Leasehold Property Improvements - straight line over 6 years

Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments

Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 29 (2024 - 29 ) .

4.	TANGIBLE FIXED ASSETS

Improvements

Fixtures

to

Plant and

and

Computer

property

machinery

fittings

equipment

Totals

£

£

£

£

£

COST

At 1 February 2024

142,763

339,341

31,722

70,463

584,289

Additions

242,193

8,767

-

4,406

255,366

At 31 January 2025

384,956

348,108

31,722

74,869

839,655

DEPRECIATION

At 1 February 2024

128,436

206,393

17,697

66,173

418,699

Charge for year

46,986

39,798

2,104

4,233

93,121

At 31 January 2025

175,422

246,191

19,801

70,406

511,820

NET BOOK VALUE

At 31 January 2025

209,534

101,917

11,921

4,463

327,835

At 31 January 2024

14,327

132,948

14,025

4,290

165,590

Fixed assets, included in the above, which are held under hire purchase contracts are as follows:

Plant and

machinery

£

COST

At 1 February 2024

and 31 January 2025

106,798

DEPRECIATION

At 1 February 2024

54,373

Charge for year

17,475

At 31 January 2025

71,848

NET BOOK VALUE

At 31 January 2025

34,950

At 31 January 2024

52,425

5.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Other debtors

19,908

82,982

6.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Bank loans and overdrafts

75,829

10,000

Hire purchase contracts (see note 8)

14,677

16,359

Trade creditors

219,587

118,030

Taxation and social security

125,913

119,490

Other creditors

49,140

58,238

485,146

322,117

7.

CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

2025

2024

£

£

Bank loans

3,333

13,333

Hire purchase contracts (see note 8)

-

14,676

3,333

28,009

8.	LEASING AGREEMENTS

Minimum lease payments fall due as follows:

Hire purchase

contracts

2025

2024

£

£

Net obligations repayable:

Within one year

14,677

16,359

Between one and five years

-

14,676

14,677

31,035

Non-cancellable

operating leases

2025

2024

£

£

Within one year

105,854

3,097

Between one and five years

368,000

-

In more than five years

644,000

-

1,117,854

3,097

9.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

2025

2024

value:

£

£

100

Ordinary

£1

100

100

10.	DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31 January 2025 and 31 January 2024:

2025

2024

£

£

Mr C R Astill-Smith

Balance outstanding at start of year

9,302

24,460

Amounts advanced

3,579

-

Amounts repaid

(9,000

)

(15,158

)

Amounts written off

-

-

Amounts waived

-

-

Balance outstanding at end of year

3,881

9,302

Miss G J Farr

Balance outstanding at start of year

2,651

2,651

Amounts advanced

101

12,237

Amounts repaid

-

(12,237

)

Amounts written off

-

-

Amounts waived

-

-

Balance outstanding at end of year

2,752

2,651